DMRA
Damora TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
DMRA vs peer average
41/100
DMRA vs. peer average (D vs. C)
Grade spread
A 1 · B 3 · C 1 · D 2 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
RNXT is the first available peer comparator.
RenovoRx is a useful loose comparator for small-cap biotech milestone sensitivity and financing risk, though it is not a direct mechanism peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
DMRA
Damora Therapeutics
RNXT
RenovoRx
Grade
D
D
Momentum
33
40
Value
41
41
Sentiment
48
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs RNXT
DMRA / RNXT
Grade Position
Below peers
DMRA vs. peer average (D vs. C)
41/100
Momentum
33
RNXTValue
41
DMRASentiment
48
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs DMRA
RNXT is the first peer returned for this comparison set.